Thierry Convard

Statistics

Publications

Citations

412

H-Index

Active since

1994

Affiliations

Idera Pharmaceuticals (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Montpellier GenomiX

Thierry Convard is an author at Idera Pharmaceuticals (United States) specializing in drug discovery, medicinal chemistry, and antiviral structure-activity relationships.

ORCID

Publications per year

1994–2018

Publications

Synthesis and Biological Evaluation of Aryl-phospho-indole as Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors

François-René Alexandre, Agnès Amador, Stéphanie Bot et al. · Journal of Medicinal Chemistry · 2010 · 179 citations

Life Sciences, Medicinal Chemistry, Pharmacokinetics +17

Discovery of the Aryl-phospho-indole IDX899, a Highly Potent Anti-HIV Non-nucleoside Reverse Transcriptase Inhibitor

Cyril B. Dousson, François-René Alexandre, Agnès Amador et al. · Journal of Medicinal Chemistry · 2016 · 73 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

SmilogP: A Program for a Fast Evaluation of Theoretical Log P from the Smiles Code of a Molecule

Thierry Convard, Jean‐Pierre Dubost, HervéLe Solleu et al. · Quantitative Structure-Activity Relationships · 1994 · 36 citations

Pharmacy, Chemistry, Medicinal Chemistry +10

The discovery of IDX21437: Design, synthesis and antiviral evaluation of 2′-α-chloro-2′-β-C-methyl branched uridine pronucleotides as potent liver-targeted HCV polymerase inhibitors

François-René Alexandre, Eric Badaroux, John P. Bilello et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 33 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Discovery and structural diversity of the hepatitis C virus NS3/4A serine protease inhibitor series leading to clinical candidate IDX320

Christophe Parsy, François-René Alexandre, Valérie Bidau et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 27 citations

Life Sciences, Infectious Diseases, Medicinal Chemistry +14

1–5 of 10